RMD

ResMed
D

RMD

Arincen97/100B

ResMed shares outstanding 1993–2027

ResMed had 140,657,000 shares outstanding on 6 November 2026. ResMed had 145.62M diluted shares on average over the last twelve months, down 1.1% on the twelve months before. In fiscal year 2026 the average was 144.98M.

Last updated 6 Nov 2026 · Next report 28 Jan 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 2026145.62M-1.09%145.16M
FY202630 Jun 2026144.98M-1.60%144.71M
FY202530 Jun 2025147.34M-0.14%146.72M
FY202430 Jun 2024147.55M+0.06%147.02M
FY202330 Jun 2023147.46M+0.28%146.77M
FY202230 Jun 2022147.04M+0.40%146.07M
FY202130 Jun 2021146.45M+0.55%145.31M
FY202030 Jun 2020145.65M+0.81%144.34M
FY201930 Jun 2019144.48M+0.35%143.11M
FY201830 Jun 2018143.99M+1.08%142.76M
FY201730 Jun 2017142.45M+0.55%141.36M
FY201630 Jun 2016141.67M-0.71%140.24M
FY201530 Jun 2015142.69M-1.16%140.47M
FY201430 Jun 2014144.36M-1.40%141.47M
FY201330 Jun 2013146.41M-1.95%142.95M
FY201230 Jun 2012149.32M-5.01%145.90M
FY201130 Jun 2011157.20M+1.35%152.47M
FY201030 Jun 2010155.10M+0.57%150.91M
FY200930 Jun 2009154.23M-2.03%151.26M
FY200830 Jun 2008157.42M+0.59%154.76M
FY200730 Jun 2007156.51M+1.41%153.42M
FY200630 Jun 2006154.32M+2.96%144.61M
FY200530 Jun 2005149.88M+6.68%137.29M
FY200430 Jun 2004140.50M+1.99%134.78M
FY200330 Jun 2003137.76M+1.05%132.22M
FY200230 Jun 2002136.32M+1.78%128.70M
FY200130 Jun 2001133.94M+3.66%124.52M
FY200030 Jun 2000129.21M+3.98%120.61M
FY199930 Jun 1999124.27M+3.32%117.66M
FY199830 Jun 1998120.28M+2.75%116.16M
FY199730 Jun 1997117.07M+4.06%117.07M
FY199630 Jun 1996112.50M+60.71%112.50M
FY199530 Jun 199570.00M+31.25%70.00M
FY199430 Jun 199453.33M+11.11%53.33M
FY199330 Jun 199348.00M—48.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about ResMed's shares

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.